Biological control as an alternative to synthetic fungicides for the management of grey and blue mould diseases of table grapes: a review.

Grey and blue mould diseases are among the most important diseases of grapes worldwide. They are causing extensive decay in postharvest grapes. Chemical fungicides remain the primary treatment for managing these diseases. However, consumer's interest in organic produce, restrictions on chemical use by some countries, and concerns about human and environmental safety have driven research to identify safe and effective alternatives. Among several alternative approaches, the use of biological control agents (BCAs) is getting more acceptance and has been comprehensively studied. This review summarizes the use of BCAs as a postharvest treatment to control the postharvest grey and blue mould of grapes. The review also emphasizes the economic importance of these two major postharvest diseases of grapes. In addition, other non-chemical postharvest treatments, the advantage of an integrated approach and finally problems, challenges, and future trends of the BCAs are described. Several yeasts that have a promising result to control grey and blue mould disease of grapes are thoroughly reviewed. The current market share of BCAs and their future directions on commercialization are also suggested in this review. Biocontrols can be a potential control method for postharvest diseases of fruits and vegetables in place of chemical fungicides. Antagonistic yeasts have high ability to suppress fungal growth. Integrated approach utilizes a combination approaches, which often results in a synergistic effect to control the diseases. USA and Europe are currently the largest markets for biocontrol products.

A Half-Century History of Applications of Antisense Oligonucleotides in Medicine, Agriculture and Forestry: We Should Continue the Journey.

Antisense oligonucleotides (ASO), short single-stranded polymers based on DNA or RNA chemistries and synthesized in vitro, regulate gene expression by binding in a sequence-specific manner to an RNA target. The functional activity and selectivity in the action of ASOs largely depends on the combination of nitrogenous bases in a target sequence. This simple and natural property of nucleic acids provides an attractive route by which scientists can create different ASO-based techniques. Over the last 50 years, planned and realized applications in the field of antisense and nucleic acid nanotechnologies have produced astonishing results and posed new challenges for further developments, exemplifying the essence of the post-genomic era. Today the majority of ASOs are chemically modified and/or incorporated within nanoparticles to enhance their stability and cellular uptake. This review critically analyzes some successful cases using the antisense approach in medicine to address severe diseases, such as Duchenne muscular dystrophy and spinal muscular atrophy, and suggests some prospective directions for future research. We also examine in detail the elaboration of unmodified insect-specific DNA insecticides and RNA preparations in the areas of agriculture and forestry, a relatively new branch of ASO that allows circumvention of the use of non-selective chemical insecticides. When considering the variety of successful ASO modifications with an efficient signal-to-noise ratio of action, coupled with the affordability of in vitro oligonucleotide synthesis and post-synthesis procedures, we predict that the next half-century will produce a fruitful yield of tools created from effective ASO-based end products.